Kraus Carl N bought AQST
March 7, 2024 · Form 4 insider transaction
Kraus Carl N bought 56,250 shares of Aquestive Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
56,250
Price
$0.00
Total value
N/A
InsiderKraus Carl N
RoleOfficer
SecurityNon-Qualified Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 7, 2024
Filing dateMarch 11, 2024
Shares owned after56,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.